Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 4 Open-market sale Chief Commercial Officer sold 16,074 shares at $7.50 ($120,528)
  2. 4 Open-market sale General Counsel sold 2,358 shares at $8.91 ($21,018)
  3. 4 Open-market sale Chief Commercial Officer sold 36,592 shares at $8.20 ($299,904)
  4. 4 Open-market sale Chief Accounting Officer sold 24,000 shares at an average $8.13 ($195,183)
  5. 4 Open-market sale Chief Commercial Officer sold 13,408 shares at an average $8.00 ($107,293)
  6. 4/A Open-market sale General Counsel sold 553 shares at $9.36 ($5,176)
  7. 4/A Open-market sale Atillasoy Ercem sold 2,095 shares at an average $8.72 ($18,272)
  8. 4/A Open-market sale Chief Accounting Officer sold 345 shares at $9.36 ($3,229)
  9. 4/A Open-market sale Chief Commercial Officer sold 1,070 shares at $9.36 ($10,016)
  10. 4/A Open-market sale Sinha Vikas sold 1,449 shares at $9.36 ($13,564)
  11. 4 Open-market sale Sinha Vikas sold 1,449 shares at $9.36 ($13,564)
  12. 4 Open-market sale Chief Commercial Officer sold 1,070 shares at $9.36 ($10,016)
  13. 4 Open-market sale Chief Accounting Officer sold 13,679 shares at an average $8.43 ($115,298)
  14. 4 Open-market sale General Counsel sold 553 shares at $9.36 ($5,176)
  15. 4 Open-market sale Atillasoy Ercem sold 2,095 shares at an average $8.72 ($18,272)
  16. 4 Open-market sale Director sold 600,000 shares at $8.45 ($5,070,000)
  17. 4 Open-market sale Director sold 400,000 shares at $7.35 ($2,940,920)
  18. 4 Open-market sale Chief Commercial Officer sold 493 shares at $7.89 ($3,889)
  19. 4 Open-market sale Chief Executive Officer sold 4,564 shares at $7.76 ($35,429)
  20. 4 Grant or award Chief Scientific Officer acquired 15,000 shares (grant or award)

Page 10 of 19 · 363 filings